Toggle Main Menu Toggle Search

Open Access padlockePrints

What's new in... Rheumatology

Lookup NU author(s): Dr Steven Young Min


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Use of COX-2 inhibitors is controversial, as doctors struggle to interpret the trials and balance gastrointestinal safety against concerns of increased cardiovascular risk. There have been improvements in immunological testing for rheumatoid arthritis (RA), with the advent of highly specific anticyclic citrullinated peptide antibodies. This article also looks at novel treatments for ankylosing spondylitis - intravenous pamidronate and antitumour necrosis factor (TNF) therapy. © 2005 The Medicine Publishing Company Ltd.

Publication metadata

Author(s): Young-Min S, Griffiths ID

Publication type: Note

Publication status: Published

Journal: Medicine

Year: 2002

Volume: 30

Issue: 8

Pages: 1-3

Print publication date: 01/01/2002

ISSN (print): 1357-3039

ISSN (electronic): 1365-4357